These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29531524)

  • 1. Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling.
    Collo G; Cavalleri L; Bono F; Mora C; Fedele S; Invernizzi RW; Gennarelli M; Piovani G; Kunath T; Millan MJ; Merlo Pich E; Spano P
    Neural Plast; 2018; 2018():4196961. PubMed ID: 29531524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.
    Cavalleri L; Merlo Pich E; Millan MJ; Chiamulera C; Kunath T; Spano PF; Collo G
    Mol Psychiatry; 2018 Apr; 23(4):812-823. PubMed ID: 29158584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.
    Bono F; Savoia P; Guglielmi A; Gennarelli M; Piovani G; Sigala S; Leo D; Espinoza S; Gainetdinov RR; Devoto P; Spano P; Missale C; Fiorentini C
    Mol Neurobiol; 2018 Feb; 55(2):1054-1067. PubMed ID: 28092083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression.
    Merlo Pich E; Cavalleri L; Toma C; Collo G
    Curr Top Behav Neurosci; 2023; 60():73-87. PubMed ID: 35538302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling.
    Collo G; Bono F; Cavalleri L; Plebani L; Mitola S; Merlo Pich E; Millan MJ; Zoli M; Maskos U; Spano P; Missale C
    Mol Pharmacol; 2013 Jun; 83(6):1176-89. PubMed ID: 23543412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T
    Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
    Presgraves SP; Borwege S; Millan MJ; Joyce JN
    Exp Neurol; 2004 Nov; 190(1):157-70. PubMed ID: 15473989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole.
    Maggio R; Scarselli M; Novi F; Millan MJ; Corsini GU
    J Neurochem; 2003 Nov; 87(3):631-41. PubMed ID: 14535946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways.
    Collo G; Bono F; Cavalleri L; Plebani L; Merlo Pich E; Millan MJ; Spano PF; Missale C
    J Neurochem; 2012 Mar; 120(5):765-78. PubMed ID: 22145570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer.
    Bono F; Mutti V; Savoia P; Barbon A; Bellucci A; Missale C; Fiorentini C
    Neurobiol Dis; 2019 Sep; 129():1-12. PubMed ID: 31051233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons.
    Matera C; Bono F; Pelucchi S; Collo G; Bontempi L; Gotti C; Zoli M; De Amici M; Missale C; Fiorentini C; Dallanoce C
    Biochem Pharmacol; 2019 May; 163():154-168. PubMed ID: 30772268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
    Lyons KE; Pahwa R
    Mov Disord; 2009 Oct; 24(14):2121-7. PubMed ID: 19768728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.
    Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Głowacka U; Kuter K; Ossowska K
    PLoS One; 2015; 10(3):e0117698. PubMed ID: 25739024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
    Joyce JN; Presgraves S; Renish L; Borwege S; Osredkar T; Hagner D; Replogle M; PazSoldan M; Millan MJ
    Exp Neurol; 2003 Nov; 184(1):393-407. PubMed ID: 14637109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
    Lee JE; Lim MS; Park JH; Park CH; Koh HC
    Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity.
    Bontempi L; Savoia P; Bono F; Fiorentini C; Missale C
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):313-324. PubMed ID: 28187919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ropinirole and pramipexole, the new agonists.
    Hobson DE; Pourcher E; Martin WR
    Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S27-33. PubMed ID: 10451757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway.
    Mutti V; Bono F; Tomasoni Z; Bontempi L; Guglielmi A; Bolognin S; Schwamborn JC; Missale C; Fiorentini C
    Mol Neurobiol; 2022 Apr; 59(4):2129-2149. PubMed ID: 35044626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.
    Wang J; Jia Y; Li G; Wang B; Zhou T; Zhu L; Chen T; Chen Y
    Int J Neuropsychopharmacol; 2018 May; 21(5):448-460. PubMed ID: 29390063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.
    Schulte-Herbrüggen O; Vogt MA; Hörtnagl H; Gass P; Hellweg R
    Eur J Pharmacol; 2012 Feb; 677(1-3):77-86. PubMed ID: 22206815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.